STAT

Before a biotech stock debacle, one Republican congressman made a prescient trade

Rep. John Culberson made a prescient sale to avoid losses when a tiny biotech's stock tanked. The stock was a favorite of several GOP representatives.
Rep. John Culberson made a prescient sale to avoid losses when a tiny biotech company's stock tanked.

A biotech stock meltdown last week led to huge paper losses for several congressional Republicans who had bought into the tiny company. But one politician-turned-investor was spared. Turns out, he had sold his shares just two weeks before news of a negative clinical trial decimated the company’s value.

Rep. John Culberson of Houston was among a half dozen House Republicans to invest in Innate Immunotherapeutics, an obscure Australian biotech company repeatedly

You're reading a preview, sign up to read more.

More from STAT

STAT2 min readScience
Following ‘CRISPR Babies’ Scandal, Senators Call For International Gene Editing Guidelines
A bipartisan trio of lawmakers introduced a new resolution that underscores their opposition to the use of CRISPR for germline editing.
STAT3 min readSociety
An Experimental AI System Can Predict When Pancreatic Cysts Will Become Cancerous
Pancreatic cancer is often deadly because it is detected too late. A new AI system outdoes humans at diagnosing which cysts are cancerous.
STAT5 min readWellness
WHO Declares Ebola Outbreak An International Health Emergency
The WHO declared the Ebola outbreak in the DRC a global health emergency, a move that is likely to escalate international attention on a crisis that has flared for a…